Stock Price
25.38
Daily Change
0.12 0.48%
Monthly
2.26%
Yearly
60.94%
Q3 Forecast
25.05

Acadia Pharmaceuticals reported $4.19B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.




Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
ALKERMES USD 4.72B 725M Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Cytokinetics USD 3.95B 846M Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Moderna USD 10.67B 290M Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Prothena USD 441M 114M Sep/2025
PTC Therapeutics USD 3.87B 148M Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025